HSD100 HER2 and Other Biomarker Testing Patterns Among Patients with Advanced Gastric Cancer (GC) or Gastric Esophageal Junction Cancer (GEJC)
Jul 1, 2022, 00:00
10.1016/j.jval.2022.04.1100
https://www.valueinhealthjournal.com/article/S1098-3015(22)01301-8/fulltext
Title :
HSD100 HER2 and Other Biomarker Testing Patterns Among Patients with Advanced Gastric Cancer (GC) or Gastric Esophageal Junction Cancer (GEJC)
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)01301-8&doi=10.1016/j.jval.2022.04.1100
First page :
Section Title :
Open access? :
No
Section Order :
10987